Justin Chakma, Chief Business Officer: ARS Pharmaceuticals SPRY Planned sale · Filed 25/11/12

Trade details

Type: Planned sale notice
Stock: ARS Pharmaceuticals SPRY
Person: Justin ChakmaChief Business Officer
Planned sale date: 25/11/12
Filed: 25/11/12

0.1% of shares outstanding to be sold

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/13~25/12/12

Justin Chakma's recent trades

Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$1.2M
136,380 sh
$1.2M
Filed 25/11/14
Traded 25/11/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$267.3K
30,000 sh
$267.3K
Filed 25/11/14
Traded 25/11/12
Justin ChakmaChief Business Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$267.4K
30,000 sh
$267.4K
Filed 25/11/12
Traded 25/11/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$1.4M
117,333 sh
$1.4M
Filed 24/12/13
Traded 24/12/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$328.9K
27,272 sh
$328.9K
Filed 24/12/13
Traded 24/12/13

Justin Chakma, Chief Officer — plans to sell 138,380 sh of ARS Pharmaceuticals SPRY · $1.2M · around 11/12 | Whalegun